However, in some instances of acute lymphoblastic leukemia (ALL), aberrant expression of EBF1 is frequently detected, adversely impacting the normal development and differentiation of B cells and associated with the occurrence, drug resistance, and recurrence of ALL [17,18,19]. Here, EBF1 is linked to acute lymphoblastic leukemia.